Jason Witherington

3.7k citations

63 papers · 2.0k indexed · h-index 26

Co-authors: Rab K. Prinjha David M. Hodgson Kuan‐I Lee Vincent Bordas David G. Smith Robert W. Ward Robert J. Ife Gareth J. Sanger
Topics: Asymmetric Synthesis and Catalysis (9 papers)Synthetic Organic Chemistry Methods (8 papers)Protein Degradation and Inhibitors (7 papers)
Cited by: Endocrine and Autonomic Systems Organic Chemistry Hematology
Journals: Proceedings of the National Academy of Sciences Journal of the American Chemical Society Angewandte Chemie International Edition
Partner nations: United Kingdom United States Japan

In The Last Decade

Jason Witherington

60 papers receiving 2.0k citations

Peers

Countries citing papers authored by Jason Witherington

Since Specialization

Citations

This map shows the geographic impact of Jason Witherington's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason Witherington with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason Witherington more than expected).

Fields of papers citing papers by Jason Witherington

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason Witherington. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason Witherington. The network helps show where Jason Witherington may publish in the future.

Co-authorship network of co-authors of Jason Witherington

This figure shows the co-authorship network connecting the top 25 collaborators of Jason Witherington. A scholar is included among the top collaborators of Jason Witherington based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason Witherington. Jason Witherington is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Human-relevant near-organ neuromodulation of the immune system via the splenic nerve 2021 ·Proceedings of the National Academy of Sciences ·Matteo Donegà,Cathrine T. Fjordbakk,(unknown),David M. Sokal,Isha Gupta,(unknown),Abbe Crawford,Simon Cook,Jaime Viscasillas,Thaleia‐Rengina Stathopoulou,Jason A. Miranda,(unknown),David Goodwin,Alison Rowles,Paul McGill,(unknown),Dirk Werling,Jason Witherington,Daniel Chew,Justin Perkins	34
2	Effect of Superior Ovarian Nerve and Plexus Nerve Sympathetic Denervation on Ovarian-Derived Infertility Provoked by Estradiol Exposure to Rats 2019 ·Frontiers in Physiology ·Miguel Del Campo,(unknown),Jason Witherington,Arun Sridhar,Hernán E. Lara	18
3	Neuronal control of experimental colitis occurs via sympathetic intestinal innervation 2017 ·Neurogastroenterology & Motility ·(unknown),Olaf Welting,(unknown),Sybren L. Meijer,Joost H.A. Folgering,(unknown),Jason Witherington,Arun Sridhar,Margriet J. Vervoordeldonk,Jurgen Seppen,Wouter J. de Jonge	51
4	Navigating CYP1A Induction and Arylhydrocarbon Receptor Agonism in Drug Discovery. A Case History with S1P ₁ Agonists 2015 ·Journal of Medicinal Chemistry ·S. Taylor,Emmanuel H. Demont,James R. Gray,Nigel Deeks,Aarti Patel,Dung N. Nguyen,Maxine Taylor,Steve R. Hood,Robert J. Watson,Rino A. Bit,(unknown),(unknown),Jason Witherington	13
5	Inhibition of osteoclastogenesis and inflammatory bone resorption by targeting BET proteins and epigenetic regulation 2014 ·Nature Communications ·Kyung‐Hyun Park‐Min,(unknown),Min Joon Lee,Sung Ho Park,Ευγενία Γιαννοπούλου,Anna Yarilina,Marjolein C. H. van der Meulen,Baohong Zhao,Nicholas Smithers,Jason Witherington,Kevin Lee,Paul P. Tak,Rab K. Prinjha,Lionel B. Ivashkiv	110
6	Place your BETs: the therapeutic potential of bromodomains 2012 ·Trends in Pharmacological Sciences ·Rab K. Prinjha,Jason Witherington,Kuan‐I Lee	159
7	The utility of pharmacokinetic–pharmacodynamic modeling in the discovery and optimization of selective S1P₁agonists 2012 ·Xenobiotica ·S. Taylor,James R. Gray,Robert Willis,Nigel Deeks,Andrea Haynes,Colin A. Campbell,(unknown),(unknown),Emmanuel H. Demont,Simon J. Dowell,Jenni Cryan,Mary A. Morse,Aarti Patel,(unknown),Jason Witherington	4
8	Progress in the Discovery of Small-Molecule Inhibitors of Bromodomain–Histone Interactions 2011 ·SLAS DISCOVERY ·Chun‐wa Chung,Jason Witherington	35
9	Functional and in situ hybridization evidence that preganglionic sympathetic vasoconstrictor neurons express ghrelin receptors 2010 ·Neuroscience ·Dorota Ferens,Lei Yin,Romke Bron,Billie Hunne,Katsuyo Ohashi‐Doi,Peter D. Kitchener,Gareth J. Sanger,Jason Witherington,Yasutake Shimizu,John B. Furness	39
10	Cognitive enhancing effects of ghrelin receptor agonists 2009 ·Psychopharmacology ·Zeenat Atcha,(unknown),(unknown),Fong Kuan Wong,(unknown),Edward R. Browne,Jason Witherington,Darrel J. Pemberton	66
11	5‐hydroxyindalpine, an agonist at the putative 5‐HT_1P receptor, has no activity on human recombinant monoamine receptors but accelerates distension‐induced peristalsis in mouse isolated colon 2009 ·Neurogastroenterology & Motility ·Nicholas A. Mitchell,(unknown),(unknown),Jason Brown,Jason Witherington,B. R. Tuladhar,Gareth J. Sanger,(unknown),Selim Cellek	2
12	Aryl sulphonyl amides as potent agonists of the growth hormone secretagogue (ghrelin) receptor 2008 ·Bioorganic & Medicinal Chemistry Letters ·Jason Witherington,(unknown),Benjamin R. Bellenie,(unknown),(unknown),David K. Dean,Alessandra Gaiba,N. Paul King,(unknown),Jon G.A. Steadman,Andrew K. Takle,Gareth J. Sanger,(unknown),Fiona C. McKay,Alison I. Muir,Kim Winborn,Robert W. Ward,Tom D. Heightman	2
13	Oral administration of a centrally acting ghrelin receptor agonist to conscious rats triggers defecation 2008 ·Neurogastroenterology & Motility ·Anthony D. Shafton,Gareth J. Sanger,Jason Witherington,Jason Brown,(unknown),(unknown),(unknown),Yasutake Shimizu,John B. Furness	33
14	(1H-Imidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: A novel class of potent MSK-1-inhibitors 2005 ·Bioorganic & Medicinal Chemistry Letters ·Mark J. Bamford,(unknown),Nicholas Bailey,Susannah Davies,David K. Dean,Alessandra Gaiba,Stephen L. Garland,John D. Harling,David Jung,(unknown),Christopher A. Parr,Jon G.A. Steadman,Andrew K. Takle,James T. Townsend,David M. Wilson,Jason Witherington	30
15	Anti-emetic activity of ghrelin in ferrets exposed to the cytotoxic anti-cancer agent cisplatin 2005 ·Neuroscience Letters ·John A. Rudd,Man P. Ngan,Man K. Wai,Andrew G. King,Jason Witherington,Paul Andrews,Gareth J. Sanger	67
16	Unsaturated 1,2-amino alcohols and ethers from aziridines and organolithiums 2004 ·Chemical Communications ·David M. Hodgson,Bogdan Štefane,Timothy J. Miles,Jason Witherington	20
17	6-Aryl-pyrazolo[3,4-b]pyridines: potent inhibitors of glycogen synthase kinase-3 (GSK-3) 2003 ·Bioorganic & Medicinal Chemistry Letters ·Jason Witherington,Vincent Bordas,Alessandra Gaiba,Neil Garton,A. Naylor,(unknown),Brian P. Slingsby,David G. Smith,Andrew K. Takle,Robert W. Ward	103
18	5-Aryl-pyrazolo[3,4-b]pyridines: potent inhibitors of glycogen synthase kinase-3 (GSK-3) 2003 ·Bioorganic & Medicinal Chemistry Letters ·Jason Witherington,Vincent Bordas,Stephen L. Garland,Deirdre M. B. Hickey,Robert J. Ife,John Liddle,Martin Saunders,David G. Smith,Robert W. Ward	95
19	Enantioselective Alkylative Double Ring Opening of Epoxides: Synthesis of Enantioenriched Unsaturated Diols and Amino Alcohols 2002 ·Angewandte Chemie International Edition ·David M. Hodgson,(unknown),Timothy J. Miles,(unknown),(unknown),Ian R. Matthews,Francis X. Wilson,Jason Witherington	26
20	Conformationally Restricted Indolopiperidine Derivatives as Potent CCR2B Receptor Antagonists 2001 ·Bioorganic & Medicinal Chemistry Letters ·Jason Witherington,Vincent Bordas,(unknown),Ian T. Forbes,Andrew D. Gribble,Robert J. Ife,Theo A. Berkhout,(unknown),Pieter H.E. Groot	35

About Jason Witherington

Jason Witherington is a scholar working on Endocrine and Autonomic Systems, Organic Chemistry and Gastroenterology, having authored 63 papers that have together received 2.0k indexed citations. Recurring topics across this work include Asymmetric Synthesis and Catalysis (9 papers), Synthetic Organic Chemistry Methods (8 papers) and Protein Degradation and Inhibitors (7 papers). The work is most often cited by research in Endocrine and Autonomic Systems (230 citations), Organic Chemistry (662 citations) and Hematology (208 citations). Jason Witherington has collaborated with scholars based in United Kingdom, United States and Japan. Frequent co-authors include Rab K. Prinjha, David M. Hodgson, Kuan‐I Lee, Vincent Bordas, David G. Smith, Robert W. Ward, Robert J. Ife, Gareth J. Sanger, Brian P. Slingsby and Chun‐wa Chung. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Angewandte Chemie International Edition.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact